Bio-Rad Laboratories is a leading provider of innovative tools to the life science and clinical diagnostics markets, where the company’s products are used for scientific discovery, drug development, and biopharmaceutical production. Bio-Rad’s Life Science Group has long served the bioprocessing industry by supplying advanced purification and process technologies. Bio-Rad provides a full line of scalable — from pilot to production — process chromatography resin and hardware solutions. Bio-Rad's process chromatography equipment and resin are used in multiple FDA approved manufacturing processes.
Introducing the Nuvia™ cPrime™ hydrophobic cation exchange resin.
- A new addition to Bio-Rad’s family of mixed-mode purification products.
Nuvia cPrime™ is designed for process-scale purification of a wide variety of therapeutic proteins. Nuvia cPrime™ resin’s unique selectivity allows method developers to use hydrophobic and cation exchange interaction modes to achieve effective purification. More importantly, the resin have a large design space for binding and elution, allowing for the development of highly robust methods in a commercial manufacturing setting.
Nuvia S & Q resin are a family of ultra high capacity ion exchangers deisgned for optimal performance in bioprocessing workflows. The resin are built on a robust base matrix with proprietary surface extender technology. We are now offering Nuvia Q™ resin. Our exciting new high capacity anion exchanger delivering excellent resolution capabilities of feedstream contaminants such as host cell proteins and doublestranded DNA. Higher productivity can be achieved by using Nuvia Q™ through faster flow rates without compromising binding capacity. Moreover, less resin is required and smaller columns can be used to purify a given amount of protein.
It’s time to add Nuvia resin to yours solution menu to deliver robust and high productivity time after time.
Join Bio-Rad Laboratories at the following events:
BPI, Boston, MA, USA October 23, 2014
Track: Novel Chromatography Selectivities
> More info
When: Thursday, October 23, 2014, 8:00 AM
Where: IBC’s BioProcess International Conference & Exhibition
Session is included with your conference registration
Ligand and Matrix Engineering for Enhanced Protein Binding Capacity, Salt Tolerance, and Mass Transfer Kinetics in Multimodal Cation Exchange Chromatography
Giorgio Carta, PhD, Quarles Professor ,Department of Chemical Engineering, University of Virginia
Production and Purification of Bispecific Antibodies using DuoBody Technology
Rick Hibbert, PhD, Scientist, Assay & Bioanalytical Science, Genmab
Leveraging Selectivity for Purification of Novel Biotherapeutics
Xuemei He, PhD, Senior Staff Scientist,Process Chromatography Applications,Bio-Rad Laboratories
Affinity Purification for Improved Process Understanding and Decision-Making in Bioprocess Development for Enzymes
Venkat Ryakala, Process Engineer, Purification Development, Genzyme, A Sanofi Company
BioProcessing Network, St. Kilda, Victoria, Australia: October 21-23, 2014
ISPPP, Wurzburg, Germany, November 5-7, 2014
Leveraging selectivity and resolution in biopharmaceutical purification
Speaker: Dr. Carsten Voss